T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortinet
FTNT
|
+$2.03B |
| 2 |
Rockwell Automation
ROK
|
+$1.44B |
| 3 |
Autodesk
ADSK
|
+$1.15B |
| 4 |
Citigroup
C
|
+$975M |
| 5 |
ConocoPhillips
COP
|
+$967M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.59B |
| 2 |
GE Aerospace
GE
|
+$1.78B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 5 |
Philip Morris
PM
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.21% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 10.99% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Communication Services | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
EnerSys
ENS
$7.42B
| $4.25M | ﹤0.01% |
45,033
+5,682
| +14% | +$534K |
|
1252
SouthState Bank Corp
SSB
$10.8B
| $4.23M | ﹤0.01% |
49,792
+2,899
| +6% | +$239K |
|
1253
Omega Healthcare
OHI
$13.9B
| $4.22M | ﹤0.01% |
133,166
+3,466
| +3% | +$105K |
|
1254
Pinnacle Financial Partners Inc
PNFP
$16.3B
| $4.21M | ﹤0.01% |
49,022
-8,114
| -14% | -$682K |
|
1255
HealthEquity
HQY
$8.84B
| $4.2M | ﹤0.01% |
51,384
+3,365
| +7% | +$263K |
|
1256
HNI Corp
HNI
$3.55B
| $4.17M | ﹤0.01% |
92,328
-3,077
| -3% | -$131K |
|
|
BNRE.A
1257
DELISTED
Brookfield Reinsurance Ltd. Class A-1 Exchangeable Non-Voting Shares
BNRE.A
| $4.16M | ﹤0.01% |
100,000
| – | – |
|
1258
Ryman Hospitality Properties
RHP
$7.98B
| $4.15M | ﹤0.01% |
35,926
+2,144
| +6% | +$246K |
|
1259
NNN REIT
NNN
$8.89B
| $4.13M | ﹤0.01% |
96,531
+5,657
| +6% | +$235K |
|
1260
STAG Industrial
STAG
$7.14B
| $4.13M | ﹤0.01% |
107,323
+4,577
| +4% | +$173K |
|
1261
Wendy's
WEN
$1.64B
| $4.12M | ﹤0.01% |
218,729
-1,422,931
| -87% | -$26.7M |
|
1262
National Fuel Gas
NFG
$7.76B
| $4.11M | ﹤0.01% |
76,526
+1,812
| +2% | +$89.6K |
|
|
BASE
1263
DELISTED
Couchbase
BASE
| $4.1M | ﹤0.01% |
155,792
-24,041
| -13% | -$625K |
|
1264
MGE Energy Inc
MGEE
$3.09B
| $4.1M | ﹤0.01% |
52,078
+3,489
| +7% | +$244K |
|
1265
Helmerich & Payne
HP
$4.41B
| $4.09M | ﹤0.01% |
97,299
-4,068
| -4% | -$154K |
|
1266
Trinity Capital Inc.
TRIN
$1.73B
| $4.08M | ﹤0.01% |
277,725
-94
| -0% | -$1.36K |
|
1267
Hawkins
HWKN
$2.69B
| $4.07M | ﹤0.01% |
52,985
+693
| +1% | +$47.6K |
|
1268
Cullen/Frost Bankers
CFR
$10.6B
| $4.06M | ﹤0.01% |
36,085
+1,906
| +6% | +$204K |
|
1269
New York Times
NYT
$10.4B
| $4.06M | ﹤0.01% |
93,988
+6,776
| +8% | +$308K |
|
1270
MasTec
MTZ
$23.2B
| $4.06M | ﹤0.01% |
43,518
+1,905
| +5% | +$145K |
|
|
SF
1271
Stifel
SF
$13B
| $4.05M | ﹤0.01% |
77,798
+3,629
| +5% | +$179K |
|
|
CIVI
1272
DELISTED
Civitas Resources
CIVI
| $4.03M | ﹤0.01% |
53,080
+2,962
| +6% | +$198K |
|
1273
Myers Industries
MYE
$1.24B
| $4.02M | ﹤0.01% |
173,382
-7,496
| -4% | -$148K |
|
1274
UroGen Pharma
URGN
$2.29B
| $4.01M | ﹤0.01% |
+267,143
| New | +$4.37M |
|
1275
Sensata Technologies
ST
$6.7B
| $3.99M | ﹤0.01% |
108,594
-21,362
| -16% | -$748K |
|
Similar funds
T. Rowe Price Associates's Q1 2024 Portfolio in Review
As of Q1 2024, T. Rowe Price Associates held 3,021 positions worth $816B, up 9.6% from $744B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2024 filing shows 108 new, 1,941 increased, 738 reduced and 64 closed positions. Its largest new stake was GE Vernova: 2,687,194 shares worth $367M. The largest sale was NVIDIA, an estimated $2.59B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2024 buy was GE Vernova: 2,687,194 shares worth $367M.
- T. Rowe Price Associates added most to Fortinet in Q1 2024, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.59B.
- T. Rowe Price Associates fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $621M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $816B portfolio in Q1 2024.
- T. Rowe Price Associates opened 108 new positions and closed 64 in Q1 2024.
- T. Rowe Price Associates's portfolio value rose 9.6% quarter-over-quarter to $816B.
Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.